Stefano De Servi, Antonio Landi, Elena Gualini, Rossana Totaro, Stefano Savonitto, Sergio Leonardi
{"title":"Neutrophil count as a risk factor for cardiovascular diseases: how can we manage it?","authors":"Stefano De Servi, Antonio Landi, Elena Gualini, Rossana Totaro, Stefano Savonitto, Sergio Leonardi","doi":"10.2459/JCM.0000000000001668","DOIUrl":"10.2459/JCM.0000000000001668","url":null,"abstract":"<p><p>Neutrophils activation plays a pivotal role in the pathogenesis of atherosclerotic plaque formation, progression and rupture. An association between the leukocyte count and the risk of developing myocardial infarction has been well known for many years; however, only recently did Mendelian randomization studies show that a high neutrophil count is a causal risk factor for atherosclerotic cardiovascular disease. On the other hand, experimental studies show that depletion of circulating neutrophils impairs plaque development. Clopidogrel, an antiplatelet agent, is widely used in combination with aspirin to reduce the incidence of ischemic events in patients treated with coronary stenting. Chronic treatment with this drug reduces inflammatory markers and neutrophil numbers, rarely causing severe leukopenia. The purpose of this review is to present recent evidence showing the link between neutrophil number and the development of cardiovascular diseases and to discuss how the clopidogrel-induced reduction in the neutrophil count may be a beneficial off-target effect of this drug.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"759-765"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giuseppe Mascia, Josep Brugada, Luca Barca, Stefano Benenati, Roberta Della Bona, Antonio Scarà, Vincenzo Russo, Elena Arbelo, Paolo Di Donna, Italo Porto
{"title":"Prognostic significance of electrophysiological study in drug-induced type-1 Brugada syndrome: a brief systematic review.","authors":"Giuseppe Mascia, Josep Brugada, Luca Barca, Stefano Benenati, Roberta Della Bona, Antonio Scarà, Vincenzo Russo, Elena Arbelo, Paolo Di Donna, Italo Porto","doi":"10.2459/JCM.0000000000001665","DOIUrl":"10.2459/JCM.0000000000001665","url":null,"abstract":"<p><strong>Background: </strong>Risk stratification in drug-induced type-1 Brugada syndrome (BrS) patients is challenging. The role of electrophysiological study (EPS) is debated as the majority of drug-induced type-1 BrS patients would not be studied according to the latest recommendations.</p><p><strong>Methods: </strong>A complete systematic literature search was performed to gauge the EPS role in this population. Three subgroups were defined: positive-EPS group, negative-EPS group, no-EPS group.</p><p><strong>Results: </strong>Among 1318 drug-induced type-1 BrS patients, no significant difference in the incidence rate of arrhythmic events was observed between groups (I2 = 45%, P for subgroup difference = 0.10) during a mean follow-up of 5.1 years, also considering symptomatic status.</p><p><strong>Conclusion: </strong>In long-term follow-up of drug-induced type-1 BrS patients, EPS does not seem to aid prognostic stratification.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"775-780"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Madaudo, Antonio Luca Maria Parlati, Daniela Di Lisi, Raffaele Carluccio, Vincenzo Sucato, Giuseppe Vadalà, Ermanno Nardi, Francesca Macaione, Antonio Cannata, Nilla Manzullo, Ciro Santoro, Adelaide Iervolino, Federica D'Angelo, Federica Marzano, Christian Basile, Paola Gargiulo, Egle Corrado, Stefania Paolillo, Giuseppina Novo, Alfredo Ruggero Galassi, Pasquale Perrone Filardi
{"title":"Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice.","authors":"Cristina Madaudo, Antonio Luca Maria Parlati, Daniela Di Lisi, Raffaele Carluccio, Vincenzo Sucato, Giuseppe Vadalà, Ermanno Nardi, Francesca Macaione, Antonio Cannata, Nilla Manzullo, Ciro Santoro, Adelaide Iervolino, Federica D'Angelo, Federica Marzano, Christian Basile, Paola Gargiulo, Egle Corrado, Stefania Paolillo, Giuseppina Novo, Alfredo Ruggero Galassi, Pasquale Perrone Filardi","doi":"10.2459/JCM.0000000000001664","DOIUrl":"10.2459/JCM.0000000000001664","url":null,"abstract":"<p><p>Artificial intelligence has increasingly become an integral part of our daily activities. ChatGPT, a natural language processing technology developed by OpenAI, is widely used in various industries, including healthcare. The application of ChatGPT in healthcare is still evolving, with studies exploring its potential in clinical decision-making, patient education, workflow optimization, and scientific literature. ChatGPT could be exploited in the medical field to improve patient education and information, thus increasing compliance. ChatGPT could facilitate information exchange on major cardiovascular diseases, provide clinical decision support, and improve patient communication and education. It could assist the clinician in differential diagnosis, suggest appropriate imaging modalities, and optimize treatment plans based on evidence-based guidelines. However, it is unclear whether it will be possible to use ChatGPT for the management of patients who require rapid decisions. Indeed, many drawbacks are associated with the daily use of these technologies in the medical field, such as insufficient expertise in specialized fields and a lack of comprehension of the context in which it works. The pros and cons of its use have been explored in this review, which was not written with the help of ChatGPT.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"766-771"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Martina Cacciapuoti, Lucia Federica Stefanelli, Federico Nalesso, Lorenzo A Calò
{"title":"Serum uric acid level and risk of cardiovascular mortality and chronic kidney disease.","authors":"Martina Cacciapuoti, Lucia Federica Stefanelli, Federico Nalesso, Lorenzo A Calò","doi":"10.2459/JCM.0000000000001666","DOIUrl":"10.2459/JCM.0000000000001666","url":null,"abstract":"","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"808-809"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Youngjin Cho, Ji Soo Kim, Joonghee Kim, Yeonyee E Yoon, Se Young Jung
{"title":"Image-based ECG analyzing deep-learning algorithm to predict biological age and mortality risks: interethnic validation.","authors":"Youngjin Cho, Ji Soo Kim, Joonghee Kim, Yeonyee E Yoon, Se Young Jung","doi":"10.2459/JCM.0000000000001670","DOIUrl":"10.2459/JCM.0000000000001670","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular risk assessment is a critical component of healthcare, guiding preventive and therapeutic strategies. In this study, we developed and evaluated an image-based electrocardiogram (ECG) analyzing an artificial intelligence (AI) model that estimates biological age and mortality risk.</p><p><strong>Methods: </strong>Using a dataset of 978 319 ECGs from 250 145 patients at Seoul National University Bundang Hospital, we developed a deep-learning model utilizing printed 12-lead ECG images to estimate patients' age (ECG-Age) and 1- and 5-year mortality risks. The model was validated externally using the CODE-15% dataset from Brazil.</p><p><strong>Results: </strong>The ECG-Age showed a high correlation with chronological age in both the internal and external validation datasets (Pearson's R = 0.888 and 0.852, respectively). In the internal validation, the direct mortality risk prediction models showed area under the curves (AUCs) of 0.843 and 0.867 for 5- and 1-year all-cause mortality, respectively. For 5- and 1-year cardiovascular mortality, the AUCs were 0.920 and 0.916, respectively. In the CODE-15%, the mortality risk predictions showed AUCs of 0.818 and 0.836 for the prediction of 5- and 1-year all-cause mortality, respectively. Compared to the neutral Delta-Age (ECG-Age - chronological age) group, hazard ratios for deaths were 1.88 [95% confidence interval (CI): 1.14-3.92], 2.12 (95% CI: 1.15-3.92), 4.46 (95% CI: 2.22-8.96) and 7.68 (95% CI: 3.32-17.76) for positive Delta-Age groups (5-10, 10-15, 15-20, >20), respectively.</p><p><strong>Conclusion: </strong>An image-based AI-ECG model is a feasible tool for estimating biological age and assessing all-cause and cardiovascular mortality risks, providing a practical approach for utilizing standardized ECG images in predicting long-term health outcomes.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"781-788"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniele Cocianni, Maria Perotto, Davide Barbisan, Stefano Contessi, Jacopo Giulio Rizzi, Giulio Savonitto, Eugenio Zocca, Enrico Brollo, Elisa Soranzo, Antonio De Luca, Enrico Fabris, Marco Merlo, Gianfranco Sinagra, Davide Stolfo
{"title":"In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure.","authors":"Daniele Cocianni, Maria Perotto, Davide Barbisan, Stefano Contessi, Jacopo Giulio Rizzi, Giulio Savonitto, Eugenio Zocca, Enrico Brollo, Elisa Soranzo, Antonio De Luca, Enrico Fabris, Marco Merlo, Gianfranco Sinagra, Davide Stolfo","doi":"10.2459/JCM.0000000000001667","DOIUrl":"10.2459/JCM.0000000000001667","url":null,"abstract":"<p><strong>Aims: </strong>Secondary mitral regurgitation (MR) negatively affects prognosis in acutely decompensated heart failure (ADHF), but can be rapidly sensitive to changes in volume status and medical interventions. We sought to assess the evolution of secondary MR in patients hospitalized for ADHF and its prognostic implications.</p><p><strong>Methods: </strong>We retrospectively enrolled 782 patients admitted for ADHF with at least two in-hospital echocardiographic evaluations of MR. We classified MR severity as none-mild or moderate-severe. Based on MR evolution, patients were divided into 'persistent moderate-severe MR', 'improved MR' (from moderate-severe to none-mild) and 'persistent none-mild MR'.</p><p><strong>Results: </strong>Four hundred and forty patients (56%) had moderate-severe MR at first evaluation, of whom 144 (33% of patients with baseline moderate-severe MR) had 'improved MR', while 296 (67%) had 'persistent moderate-severe MR'. Patients with improved MR had better clinical, laboratory and echocardiographic parameters of decongestion at discharge compared with those with persistent moderate-severe MR and showed a higher up-titration of recommended therapies. Left ventricular volume, ejection fraction and serum urea were the predictors of improved MR at multivariable analysis. After adjustment, no differences in 5-years survival (primary outcome) were observed according to baseline MR severity. When patients were stratified according to the in-hospital changes in MR severity, improved MR was associated with lower risk of 5-years mortality, compared with both persistent none-mild MR [hazard ratio (HR) = 0.505, P = 0.032] and persistent moderate-severe MR (HR = 0.556, P = 0.040).</p><p><strong>Conclusions: </strong>The severity of MR frequently improved during hospitalization for ADHF; the extent and the changes in MR severity during the in-hospital stay identified distinct patient phenotypes, and seemed to portend different long-term outcomes, with higher 5-years survival associated with improvement in MR.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"789-798"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Could ChatGPT become a future cardiologist? Navigating requirements and risks.","authors":"Youngjin Cho, Joonghee Kim","doi":"10.2459/JCM.0000000000001663","DOIUrl":"10.2459/JCM.0000000000001663","url":null,"abstract":"","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"772-774"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Massimo Imazio, Flavio Faletra, Jessica Zucco, Catia Mio, Matteo Carraro, Alberto Maria Gava, Marzia De Biasio, Giuseppe Damante, Valentino Collini
{"title":"Genetic variants in patients with recurrent pericarditis.","authors":"Massimo Imazio, Flavio Faletra, Jessica Zucco, Catia Mio, Matteo Carraro, Alberto Maria Gava, Marzia De Biasio, Giuseppe Damante, Valentino Collini","doi":"10.2459/JCM.0000000000001669","DOIUrl":"10.2459/JCM.0000000000001669","url":null,"abstract":"<p><strong>Aims: </strong>Presence of family cases and multiple recurrences of pericarditis suggest the existence of a possible genetic background in at least 10% of cases. The aim of the present study is to describe the genetic landscape of a cohort of patients with multiple recurrences (at least two recurrences).</p><p><strong>Methods: </strong>Retrospective cohort study of consecutive adult patients referred for at least two episodes of recurrences in a tertiary referral centre. Genetic testing was performed by whole exome sequencing (WES).</p><p><strong>Results: </strong>Our cohort included 108 consecutive patients with recurrent pericarditis [median age 32 years, interquartile range (IQR) 18.5; 67.6% females, all Caucasian, idiopathic aetiology in 71.1%] with a median number of recurrences of 5 (IQR 2). Overall, 16 patients (14.8%) had variants in genes related to the inflammatory response. Eleven variants were located in genes already associated with recurrent pericarditis (NLRP3, TNFRSF1A and MEFV) and five in inflammation/immunodeficiency-related genes (IFIH1, NFKBIA, JAK1, NOD2 and ALPK1). Furthermore, we identified 10 patients with variants located in genes associated with conduction system-related diseases, and 22 variants in 21 patients with genes associated with heart structural-related diseases.</p><p><strong>Conclusion: </strong>In this first observational study using WES to assess genetic variants in patients with multiple recurrences of pericarditis, about 15% of patients bore at least one variant that may be related to the disease. These findings highlight the importance of addressing the role of genetic predisposition in recurrent pericarditis. Moreover, 28.7% of patients carry variants in different cardiac genes, worthy of a deeper investigation.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"799-804"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Conduit flow computation is the missing key to understanding the potential effects of left-to-right shunting in heart failure patients.","authors":"Paolo N Marino, Jacopo Zanaboni, Alice Panizza","doi":"10.2459/JCM.0000000000001672","DOIUrl":"10.2459/JCM.0000000000001672","url":null,"abstract":"","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 11","pages":"805-807"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marco Mojoli, Pier Luigi Temporelli, Daniela Pavan, Maurizio Giuseppe Abrignani, Lucio Gonzini, Donata Lucci, Federico Piscione, Stefano Provasoli, Michele Massimo Gulizia, Domenico Gabrielli, Furio Colivicchi, Fabrizio Oliva, Leonardo De Luca
{"title":"Sex-related differences in demographics, diagnosis and management of patients with chronic coronary syndromes.","authors":"Marco Mojoli, Pier Luigi Temporelli, Daniela Pavan, Maurizio Giuseppe Abrignani, Lucio Gonzini, Donata Lucci, Federico Piscione, Stefano Provasoli, Michele Massimo Gulizia, Domenico Gabrielli, Furio Colivicchi, Fabrizio Oliva, Leonardo De Luca","doi":"10.2459/JCM.0000000000001675","DOIUrl":"https://doi.org/10.2459/JCM.0000000000001675","url":null,"abstract":"<p><strong>Aims: </strong>The impact of sex-related factors on current clinical management and outcomes of chronic coronary syndromes (CCS) are unclear.</p><p><strong>Methods: </strong>All patients belonging to the prospective, nationwide START registry were included. Their baseline characteristics, diagnostic workup, revascularization strategy, pharmacological treatment and 1-year clinical outcomes were compared with respect to sex overall and in age tertiles.</p><p><strong>Results: </strong>A total of 5070 consecutive patients were included. Most patients were males (80.1%). As expected, the prevalence of females increased with age. Distribution of risk factors and history of cardiovascular disease were different depending on sex, as well as diagnostic workup, with lower use of exercise stress testing in women (25.1% vs. 36.7%, P < 0.0001). The use of coronary angiography was similar in the two groups. Women had lower rates of multivessel coronary artery disease (CAD) (33.0% vs. 40.6% P < 0.0001) and higher rates of nonobstructive CAD (18.3% vs. 11.3%, P < 0.0001). Rates of myocardial revascularization were similar, but women were more likely to receive percutaneous coronary intervention than men (84.3% vs. 77.8%, P < 0.0001) and less likely to receive surgical/hybrid revascularization (10.0% vs. 15.1%, P < 0.0001). At 12-month follow-up, no differences were observed for the combined endpoint of all-cause mortality, re-hospitalization for myocardial infarction, heart failure, stroke or myocardial revascularization between males and females; however, a significantly worse perceived quality of life was observed in women.</p><p><strong>Conclusions: </strong>In a large nationwide cohort of patients with CCS, clinical outcomes were not different depending on sex. However, several differences in the diagnostic work-up, treatment strategies and quality of life were found between sexes.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}